CRISPR-Cas12a enables cutting-edge diagnostics, study

CRISPR-Cas12a t an ideal enzyme for simple, rapid and accurate disease diagnostics.

Blood sample
iStock

Originally discovered in 2015, CRISPR-CAS12a, one of the DNA-cutting protein now turned into a most powerful tool for disease diagnostics. It has supercharged natural research in a negligible six years, accelerating investigation of the reasons for infection and starting numerous potential new treatments.

But co-first authors Janice Chen, Enbo Ma and Lucas Harrington in Doudna’s lab discovered that when Cas12a binds and cuts a targeted double-stranded DNA sequence, it unexpectedly unleashes indiscriminate cutting of all single-stranded DNA in a test tube.

Doudna, a professor of molecular and cell biology said, “We continue to be fascinated by the functions of bacterial CRISPR systems and how mechanistic understanding leads to opportunities for new technologies.”

Thus, scientists at the UC Berkeley have developed a diagnostic system called DNA Endonuclease Targeted CRISPR Trans Reporter, or DETECTR. The DETECTR can also be considered as quick and easy point-of-care detection of even small amounts of DNA in clinical samples.

It includes including all reagents in a solitary response: CRISPR-Cas12a and its RNA focusing on arrangement (direct RNA), fluorescent journalist atom and an isothermal intensification framework called recombinase polymerase enhancement (RPA), which is like polymerase chain response (PCR). At the point when warmed to body temperature, RPA quickly duplicates the number of duplicates of the objective DNA, boosting the odds Cas12a will discover one of them, tie and release single-strand DNA cutting, bringing about a fluorescent readout.

The new DETECTR system based on CRISPR-Cas12a can analyze cells, blood, saliva, urine and stool to detect genetic mutations, cancer and antibiotic resistance as well as diagnose bacterial and viral infections. Target DNA is amplified by RPA to make it easier for Cas12a to find it and bind, unleashing indiscriminate cutting of single-stranded DNA, including DNA attached to a fluorescent marker (gold star) that tells researchers that Cas12a has found its target.
The new DETECTR system based on CRISPR-Cas12a can analyze cells, blood, saliva, urine and stool to detect genetic mutations, cancer, and antibiotic resistance as well as diagnose bacterial and viral infections. Target DNA is amplified by RPA to make it easier for Cas12a to find it and bind, unleashing indiscriminate cutting of single-stranded DNA, including DNA attached to a fluorescent marker (gold star) that tells researchers that Cas12a has found its target.

Scientists conducted experiments with patient samples containing human papillomavirus (HPV). Using DETECTR, they were able to detect the “high-risk” HPV types 16 and 18 in samples very precisely.

Chen said, “This protein works as a robust tool to detect DNA from a variety of sources. We want to push the limits of the technology, which is potentially applicable in any point-of-care diagnostic situation where there is a DNA component, including cancer and infectious disease.”

“The indiscriminate cutting of all single-stranded DNA, which the researchers discovered holds true for all related Cas12 molecules, but not Cas9, may have unwanted effects in genome editing applications, but more research is needed on this topic. During the transcription of genes, for example, the cell briefly creates single strands of DNA that could accidentally be cut by Cas12a.”

According to scientists, this new tool is repurposed from their unique part in organisms where they fill in as versatile insusceptible frameworks to fight off viral diseases. In these microbes, Cas proteins store records of past contaminations and utilize these “memories” to recognize hurtful DNA amid diseases. Cas12a, the protein utilized as a part of this examination, at that point cuts the attacking DNA, sparing the microorganisms from being assumed control by the infection.

HHMI DETECTR Infographic by the Howard Hughes Medical Institute
HHMI DETECTR Infographic by the Howard Hughes Medical Institute

Chen said, “The chance discovery of Cas12a’s unusual behavior highlights the importance of basic research since it came from a basic curiosity about the mechanism Cas12a uses to cleave double-stranded DNA.”

“It’s cool that, by going after the question of the cleavage mechanism of this protein, we uncovered what we think is a very powerful technology used in an array of applications.”

The UC Berkeley researchers, along with their colleagues at UC San Francisco, have published their findings on Feb. 15 in Science.